CALL US NOW 0207 939 0780
PLEASE DONATE

Archive for February, 2017

Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation

New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be monitored and managed.

Read More

Westminster Justice Summit

The Haemophilia Society attended the Westminster Justice Summit today, hosted by Andy Burnham MP. At the event representatives from a large number of justice campaigns, including campaigners on contaminated blood shared their situations and challenges with the group. In his comments, Andy Burnham said there was a need to rebalance

Read More